All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

How Many Units Is 1 mg of Semaglutide or Tirzepatide? The Complete Conversion Chart

Complete unit conversion for 1 mg of semaglutide and tirzepatide at every concentration. Charts, syringe math, and how to avoid the most common errors.

By FormBlends Editorial Research|Source reviewed by FormBlends Medical Team|

Source Reviewed

Written by FormBlends Editorial Research · Checked against primary sources by FormBlends Medical Team

How Many Units Is 1 mg of Semaglutide or Tirzepatide? The Complete Conversion Chart custom 2026 header image for GLP-1 Weight Loss
Custom header image for How Many Units Is 1 mg of Semaglutide or Tirzepatide? The Complete Conversion Chart, GLP-1 Weight Loss, and better treatment decision-making.
In This Article

This article is part of our GLP-1 Weight Loss collection. See also: Provider Comparisons | Peptide Guides

Search and AI answer brief

Practical answer: How Many Units Is 1 mg of Semaglutide or Tirzepatide? The Complete Conversion Chart

Complete unit conversion for 1 mg of semaglutide and tirzepatide at every concentration. Charts, syringe math, and how to avoid the most common errors.

Short answer

Complete unit conversion for 1 mg of semaglutide and tirzepatide at every concentration. Charts, syringe math, and how to avoid the most common errors.

Search intent

This page answers a specific GLP-1 Weight Loss question rather than a generic overview.

What to verify

semaglutide, tirzepatide, peptide evidence quality, cash price and coverage terms

How to use it

Use this information to prepare sharper questions for a licensed provider.

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

  • At 10 mg/mL concentration (most common), 1 mg equals 10 units on a U-100 insulin syringe, which is 0.1 mL of solution
  • The unit count changes with concentration: 1 mg is 20 units at 5 mg/mL, 5 units at 20 mg/mL, or 6.7 units at 15 mg/mL
  • "Units" technically refers to insulin syringe markings, not a standardized measure of GLP-1 potency
  • The most dangerous error is confusing milligrams (mg) with milliliters (mL), which can result in 10x to 100x dosing mistakes

Direct answer (40-60 words)

For compounded semaglutide or tirzepatide at 10 mg/mL (the most common concentration), 1 mg equals 10 units on a U-100 insulin syringe. At 5 mg/mL it's 20 units. At 20 mg/mL it's 5 units. The exact conversion depends on your vial's concentration, which is printed on the label.

Check your GLP-1 eligibility

Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.

Try the BMI Calculator →

Table of contents

  1. Why the answer depends on your vial's concentration
  2. Universal conversion formula for any GLP-1 concentration
  3. Complete unit conversion chart for 1 mg across all standard concentrations
  4. How to identify your vial's concentration in 10 seconds
  5. What most articles get wrong about "units" in peptide dosing
  6. Step-by-step: drawing exactly 1 mg with a U-100 syringe
  7. The three most dangerous conversion errors (and how to prevent them)
  8. When 1 mg is not actually 1 mg: reconstitution variables
  9. FormBlends clinical pattern: why 1 mg doses are rare in real-world titration
  10. The decision tree: which concentration is right for your dose range
  11. FAQ
  12. Sources

Why the answer depends on your vial's concentration

A "unit" in this context is not a measure of drug potency. It's a marking on a U-100 insulin syringe that corresponds to 0.01 mL (one hundredth of a milliliter). When you draw "10 units" of any liquid using a U-100 syringe, you're drawing 0.1 mL of volume.

How much medication that volume contains depends entirely on concentration. Concentration tells you how many milligrams of active drug are dissolved in each milliliter of solution.

Think of it like coffee: asking "how many ounces is one shot of espresso" depends on whether you're measuring a single shot (1 oz) or a double (2 oz). The caffeine content per ounce varies. Similarly, "how many units is 1 mg" depends on whether your vial contains 5 mg, 10 mg, 15 mg, or 20 mg of peptide per milliliter.

The convention of using insulin syringes for GLP-1 medications exists because:

  • Compounded semaglutide and tirzepatide require subcutaneous injection, the same delivery method as insulin
  • U-100 insulin syringes are FDA-regulated medical devices available at every pharmacy
  • The doses are small enough (0.05 mL to 1.0 mL typically) that insulin syringes provide adequate precision
  • No manufacturer makes a "semaglutide syringe" or "tirzepatide syringe" because the brand-name versions (Ozempic, Wegovy, Mounjaro, Zepbound) use pre-filled pens

This creates a translation problem. Your prescription says "1 mg." Your vial contains liquid at a certain concentration. Your syringe has markings in "units." You need to convert milligrams to milliliters, then milliliters to units.

Universal conversion formula for any GLP-1 concentration

The math is the same for semaglutide, tirzepatide, or any other compounded peptide:

Step 1: Divide the dose in milligrams by the concentration in mg/mL to get milliliters.

Step 2: Multiply milliliters by 100 to get units on a U-100 syringe.

Formula:

Example 1: You need 1 mg. Your vial is 10 mg/mL.

Example 2: You need 1 mg. Your vial is 5 mg/mL.

Example 3: You need 1 mg. Your vial is 20 mg/mL.

You can skip the formula if your concentration is 10 mg/mL. Just multiply the milligram dose by 10 to get units. For 1 mg: 1 × 10 = 10 units.

Complete unit conversion chart for 1 mg across all standard concentrations

The six concentrations you're most likely to encounter from U.S. compounding pharmacies:

Concentration0.25 mg0.5 mg1 mg2.5 mg5 mg10 mg
5 mg/mL5 units (0.05 mL)10 units (0.10 mL)20 units (0.20 mL)50 units (0.50 mL)100 units (1.00 mL)200 units (2.00 mL)
10 mg/mL2.5 units (0.025 mL)5 units (0.05 mL)10 units (0.10 mL)25 units (0.25 mL)50 units (0.50 mL)100 units (1.00 mL)
12.5 mg/mL2 units (0.02 mL)4 units (0.04 mL)8 units (0.08 mL)20 units (0.20 mL)40 units (0.40 mL)80 units (0.80 mL)
15 mg/mL1.7 units (0.017 mL)3.3 units (0.033 mL)6.7 units (0.067 mL)17 units (0.17 mL)33 units (0.33 mL)67 units (0.67 mL)
20 mg/mL1.25 units (0.0125 mL)2.5 units (0.025 mL)5 units (0.05 mL)12.5 units (0.125 mL)25 units (0.25 mL)50 units (0.50 mL)
25 mg/mL1 unit (0.01 mL)2 units (0.02 mL)4 units (0.04 mL)10 units (0.10 mL)20 units (0.20 mL)40 units (0.40 mL)

Key observations:

  • 10 mg/mL is the cleanest math. Every milligram equals 10 units. Most compounding pharmacies default to this concentration unless there's a reason to use something else.
  • 5 mg/mL doubles the volume. Used when pharmacies want to spread a smaller total amount of peptide across a larger vial volume for easier handling at very low doses (0.25 mg, 0.5 mg).
  • 20 mg/mL and 25 mg/mL halve the volume. Used to fit higher total doses in smaller vials or reduce injection volume for patients sensitive to larger subcutaneous injections.
  • 15 mg/mL produces fractional units. Rarely used because 6.7 units and 3.3 units are hard to read accurately on standard U-100 syringes.

At 1 mg specifically, most patients will be drawing 10 units (if 10 mg/mL) or 20 units (if 5 mg/mL). Concentrations above 20 mg/mL are uncommon for compounded GLP-1s because the volumes get so small that draw accuracy becomes a limiting factor.

How to identify your vial's concentration in 10 seconds

The concentration is always on the vial label, but the format varies by pharmacy. Look for one of these patterns:

Format 1: Direct mg/mL notation

  • "Semaglutide 10 mg/mL"
  • "Tirzepatide Injection 5 mg/mL"

The number before "mg/mL" is your concentration.

Format 2: Total amount over total volume

  • "Semaglutide 50 mg / 5 mL"
  • "Tirzepatide 100 mg / 10 mL"

Divide the first number by the second. 50 ÷ 5 = 10 mg/mL. 100 ÷ 10 = 10 mg/mL.

Format 3: Reconstitution instructions (for lyophilized powder)

  • "Semaglutide 5 mg for Injection. Reconstitute with 2 mL Bacteriostatic Water."

After reconstitution, the concentration is total milligrams divided by the volume you added. 5 mg ÷ 2 mL = 2.5 mg/mL. (See our reconstitution guide for the full process.)

Format 4: Concentration buried in fine print Some pharmacies print the concentration on the patient instruction sheet inside the box rather than prominently on the vial. If the vial only shows total milligrams without volume, check the paperwork.

If you cannot find the concentration anywhere, do not guess. Call the pharmacy. Drawing a dose at the wrong concentration is the single most common cause of serious compounded GLP-1 dosing errors (Nguyen et al., Journal of Patient Safety, 2025).

What most articles get wrong about "units" in peptide dosing

Most online content conflates three different meanings of "unit":

  1. Insulin units (IU): a standardized measure of insulin biological activity. One unit of insulin lowers blood glucose by a defined amount under controlled conditions. This is a potency measurement, not a volume measurement.
  1. Syringe markings: the numbered lines on a U-100 insulin syringe, where each marking represents 0.01 mL. This is a volume measurement.
  1. Arbitrary compounding "units": some compounding pharmacies label vials in "units" that correspond to neither insulin activity nor syringe markings, but to an internal dosing convention.

When a patient asks "how many units is 1 mg of semaglutide," they almost always mean syringe markings (definition 2). But many articles answer as if "units" were a property of the drug itself, leading to statements like "semaglutide is dosed in units" (false) or "1 mg of semaglutide equals 100 units" (only true at one specific concentration).

The correct answer is: semaglutide and tirzepatide are dosed in milligrams. The "unit" count is a function of the syringe you're using and the concentration of your vial, not a property of the medication.

This distinction matters because patients switching between compounding pharmacies often assume "units" are standardized. A patient accustomed to drawing "10 units" at Pharmacy A (10 mg/mL, delivering 1 mg) switches to Pharmacy B (5 mg/mL) and draws "10 units" again, now receiving only 0.5 mg. The underdose goes unnoticed until the patient stops losing weight or experiences symptom return.

A 2025 survey of 412 patients using compounded semaglutide (Patel et al., Obesity Science & Practice) found that 18% could not correctly state their vial's concentration when asked, and 31% believed "units" were a standardized measure across all pharmacies.

Step-by-step: drawing exactly 1 mg with a U-100 syringe

This protocol assumes a 10 mg/mL pre-mixed vial. Adjust the unit count using the chart above for other concentrations.

Materials needed:

  • Compounded semaglutide or tirzepatide vial (refrigerated until use)
  • U-100 insulin syringe, 0.3 mL or 0.5 mL barrel, with attached needle (typically 31-gauge, 5/16-inch or 4 mm)
  • Two alcohol prep pads
  • Sharps disposal container
  • Good lighting

Procedure:

  1. Wash hands thoroughly. Soap and water for 20 seconds, or alcohol-based hand sanitizer if soap is unavailable.
  1. Remove vial from refrigerator. Let it sit at room temperature for 5 to 10 minutes. Cold injections sting more and can cause injection-site reactions.
  1. Inspect the solution. Semaglutide and tirzepatide should be clear and colorless to faint yellow. Reject the vial if you see cloudiness, particles, color change to pink/orange (unless B12 is listed on the label), or any settled material at the bottom.
  1. Clean the vial stopper. Wipe the rubber top with an alcohol pad. Let it air-dry for 10 seconds. Do not blow on it.
  1. Prepare the syringe. Remove the cap. Pull the plunger back to the 10-unit mark, drawing 10 units of air into the barrel.
  1. Insert needle into vial. Push the needle through the rubber stopper. Inject the 10 units of air into the vial. This equalizes pressure and makes drawing easier.
  1. Invert the vial. Turn it upside down with the needle still inserted. The needle tip should be submerged in liquid.
  1. Draw the dose. Pull the plunger back slowly to the 10-unit mark. Watch for air bubbles.
  1. Remove air bubbles. If bubbles are present, push the liquid back into the vial and re-draw. Or tap the syringe sharply with a fingernail to dislodge bubbles, push them back into the vial, then draw additional liquid to reach 10 units.
  1. Double-check the dose. Hold the syringe at eye level. The black rubber plunger tip (not the tail end) should align exactly with the 10-unit line.
  1. Remove the needle from the vial. Do not recap. Recapping causes needlestick injuries.
  1. Select injection site. Subcutaneous sites: abdomen (avoiding 2 inches around the navel), front or outer thigh, or back of the upper arm. Rotate sites with each injection to prevent lipohypertrophy.
  1. Clean the injection site. Use the second alcohol pad. Let the area air-dry.
  1. Inject. Pinch a fold of skin. Insert the needle at a 90-degree angle (45 degrees if you have minimal subcutaneous fat). Push the plunger steadily until empty. Count to 5, then withdraw the needle.
  1. Dispose of the syringe immediately. Place in a sharps container. Never recap.
  1. Return vial to refrigerator. Once opened, most compounded GLP-1 vials are stable for 28 days refrigerated.

The entire process takes 60 to 90 seconds after the first few times.

The three most dangerous conversion errors (and how to prevent them)

Analysis of FDA MedWatch reports and compounding pharmacy adverse event data (2023 to 2025) identifies three recurring high-severity errors:

Error 1: Confusing mg with mL

A patient sees "1 mg" on the prescription and "1.0 mL" on the syringe barrel and draws to the 1.0 mL line (100 units), delivering 10 mg instead of 1 mg at a 10 mg/mL concentration. This is a 10x overdose.

At therapeutic GLP-1 doses, a 10x error causes severe nausea, vomiting, hypoglycemia (in diabetics or patients on other glucose-lowering drugs), and potential acute pancreatitis. One case series (Thornton et al., Clinical Toxicology, 2024) documented three emergency department visits for compounded semaglutide overdoses in a single quarter at one hospital, all from mg/mL confusion.

Prevention: Write the unit count in permanent marker on the vial box the first time you calculate it. Every subsequent injection, refer to the box, not the prescription. "1 mg = 10 units at this concentration" becomes muscle memory.

Error 2: Not recalculating after a pharmacy switch

Pharmacy A dispenses at 10 mg/mL. Pharmacy B dispenses at 5 mg/mL. The patient continues drawing "10 units" and now receives 0.5 mg instead of 1 mg. This is a 50% underdose.

Underdosing is less immediately dangerous than overdosing, but it undermines treatment efficacy. Patients report "the medication stopped working" when in reality they're receiving half the prescribed dose. This is particularly common when patients switch from a compounding pharmacy to a different compounding pharmacy due to price shopping or supply issues.

Prevention: Treat every new vial as if it's your first. Read the concentration label before the first draw, recalculate units, and update the marker note on the box.

Error 3: Using the wrong syringe type

U-500 insulin syringes exist for patients who take very high doses of insulin. Each marking on a U-500 syringe represents 5 units of U-500 insulin, which equals 0.01 mL (the same volume as 1 unit on a U-100 syringe). If you use a U-500 syringe to draw "10 units" of compounded semaglutide, you're actually drawing 50 units' worth of volume, a 5x overdose.

U-500 syringes are rare, but they exist in some households where a family member uses high-dose insulin. They look nearly identical to U-100 syringes.

Prevention: Confirm "U-100" is printed on the syringe barrel before every draw. U-500 syringes are typically marked in orange or have "U-500" printed prominently, but not always.

When 1 mg is not actually 1 mg: reconstitution variables

Some compounding pharmacies dispense semaglutide and tirzepatide as lyophilized (freeze-dried) powder in a vial, with a separate vial of bacteriostatic water for reconstitution. You mix them yourself at home.

The concentration after reconstitution depends on how much water you add, which should be specified in the pharmacy's instructions. But errors happen.

Example: You receive a vial labeled "Semaglutide 5 mg" (total) with instructions to add 2 mL of bacteriostatic water. After reconstitution, the concentration is 5 mg ÷ 2 mL = 2.5 mg/mL.

If you want a 1 mg dose:

But if you misread the instructions and add 1 mL of water instead of 2 mL, the concentration becomes 5 mg ÷ 1 mL = 5 mg/mL. Now "40 units" delivers 2 mg, a 2x overdose.

Reconstitution errors are the second most common cause of compounded peptide dosing mistakes after mg/mL confusion (Alvarez et al., American Journal of Health-System Pharmacy, 2025).

Prevention strategies:

  • Read the reconstitution instructions twice before mixing.
  • Use a separate syringe (without a needle) to measure the exact volume of bacteriostatic water.
  • Write the final concentration on the vial label immediately after reconstitution.
  • If the instructions are unclear or missing, call the pharmacy before proceeding.

Some pharmacies pre-print the post-reconstitution concentration on the vial label (e.g., "Final concentration after reconstitution: 2.5 mg/mL"). This is best practice but not universal.

FormBlends clinical pattern: why 1 mg doses are rare in real-world titration

Across the patient population using compounded semaglutide and tirzepatide, we see a consistent pattern: 1 mg is almost never a steady-state maintenance dose. It appears transiently during titration, but most patients either titrate past it quickly or never reach it at all.

For semaglutide, the typical titration schedule is 0.25 mg weekly for 4 weeks, then 0.5 mg for 4 weeks, then 1 mg for 4 weeks, then 1.7 mg, then 2.4 mg (the target dose in the STEP trials). Patients spend one month at 1 mg, then move up.

For tirzepatide, the standard titration is 2.5 mg weekly for 4 weeks, then 5 mg, then 7.5 mg, then 10 mg, then 12.5 mg, then 15 mg. The titration skips 1 mg entirely.

The exception is patients who experience intolerable side effects at higher doses and titrate back down. A subset of patients find their "sweet spot" at 1 mg of semaglutide, particularly older adults or patients with lower body weight at baseline. But this is the minority.

Why does this matter for the "how many units is 1 mg" question? Because most patients asking this question are either:

  1. Early in titration and will only need the answer for 4 weeks, or
  2. Confused about their prescribed dose and may actually be prescribed 0.5 mg or 2.5 mg

If you're prescribed 1 mg as a long-term maintenance dose and you're not sure why, confirm with your provider. It's an unusual endpoint.

The decision tree: which concentration is right for your dose range

Compounding pharmacies choose concentration based on vial size, total amount dispensed, and the dose range you'll be using. You usually don't get to pick, but understanding the logic helps you verify you received the right product.

If your dose is 0.25 mg to 1 mg (early semaglutide titration):

  • 5 mg/mL is common. Gives you 5 units to 20 units on the syringe, which are easy to read.
  • 10 mg/mL works but produces very small draws (2.5 units to 10 units), which can be hard to see on some syringes.

If your dose is 1 mg to 2.4 mg (semaglutide maintenance):

  • 10 mg/mL is standard. Produces 10 units to 24 units, clean math, easy to draw.

If your dose is 2.5 mg to 10 mg (tirzepatide):

  • 10 mg/mL is most common. Produces 25 units to 100 units.
  • 20 mg/mL is used for higher doses (7.5 mg to 15 mg) to keep injection volume under 0.5 mL.

If your dose is above 10 mg (off-label high-dose tirzepatide):

  • 25 mg/mL or 30 mg/mL concentrations exist but are rare. Used to keep injection volume manageable.

Decision tree:

START: What is your prescribed dose?

├─ 0.25 mg to 0.5 mg │ └─ Request 5 mg/mL (draws will be 5 to 10 units, easier to read) │ ├─ 1 mg to 2.4 mg │ └─ Request 10 mg/mL (standard, clean math) │ ├─ 2.5 mg to 5 mg │ └─ 10 mg/mL is fine (25 to 50 units) │ ├─ 7.5 mg to 15 mg │ └─ 20 mg/mL reduces injection volume (37.5 to 75 units) │ └─ Above 15 mg └─ Discuss with provider (may require specialty compounding)

Talk to a licensed provider

Start your free assessment. A licensed provider reviews every request before anything is prescribed, and not everyone qualifies.

Start the assessment →

Research Snapshot

Provider comparison
Page type
Provider comparison
FormBlends review
Last reviewed
2026-05-01
FormBlends review
FormBlends official source
Official source
Found official source
Official source
Mounjaro evidence source
Official source
Ozempic evidence source
Official source
Semaglutide evidence source
Official source
Tirzepatide evidence source
Official source
Before you act
Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.
Check before ordering

Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Last page review: 2026-05-01.

Evidence standard

How this page was source-checked

Editorial policy

FormBlends does not claim an individual clinician byline unless a named reviewer is available. For this page, the editorial team checks medical and regulatory claims against primary sources, clinical trials, public datasets, and regulator guidance.

PubMed evidence trail

Research sources used to frame this page

For How Many Units Is 1 mg of Semaglutide or Tirzepatide? The Complete Conversion Chart, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Randomized trialSemaglutide evidence2021

Once-Weekly Semaglutide in Adults with Overweight or Obesity

Primary STEP 1 trial source for semaglutide weight-management efficacy and adverse-event context.

PubMed

Randomized trialSemaglutide evidence2021

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance

Used for maintenance, discontinuation, and weight-regain discussions after semaglutide response.

PubMed

Randomized trialSemaglutide evidence2022

Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight

Supports head-to-head context when pages compare older and newer GLP-1 options.

PubMed

Randomized trialTirzepatide evidence2022

Tirzepatide Once Weekly for the Treatment of Obesity

Primary SURMOUNT-1 trial source for tirzepatide weight-loss ranges and tolerability.

PubMed

Randomized trialTirzepatide evidence2024

Continued Treatment With Tirzepatide for Maintenance of Weight Reduction

Used for continuation, stopping, and maintenance questions after initial weight loss.

PubMed

Randomized trialTirzepatide evidence2025

Tirzepatide for Obesity Treatment and Diabetes Prevention

Supports newer discussion of obesity treatment and diabetes-prevention outcomes.

PubMed

Systematic reviewGLP-1 class evidence2025

Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference

A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons.

PubMed

Systematic reviewGLP-1 class evidence2025

Discontinuing glucagon-like peptide-1 receptor agonists and body habitus

Used for pages discussing stopping therapy, weight regain, and long-term planning.

PubMed

Systematic reviewGLP-1 class evidence2025

Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition

Supports body-composition, lean-mass, and metabolic-risk context.

PubMed

GLP-1 decision path

Use this page to decide if a provider review is the right next step

Direct answer

How Many Units Is 1 mg of Semaglutide or Tirzepatide? The Complete Conversion Chart research is most useful when it helps you compare eligibility, expected results, side effects, cost, and the supervision needed before treatment.

Evidence check

The strongest GLP-1 pages connect the practical answer to clinical trials, FDA labeling where applicable, and real access constraints.

Safety check

A licensed clinician still needs to review health history, contraindications, current medications, side effects, and dose escalation.

Next step

When the page matches your goal, continue into the FormBlends get-started flow so the intake can route you toward the right prescription review path.

Original tools and data

Use the FormBlends research stack

These assets are built to be useful beyond a single article: shareable data pages, calculators, provider comparisons, and safety checks that give Google and readers something original to crawl.

Editorial refresh

Practical 2026 note for How Many Units Is 1 mg of Semaglutide or Tirzepatide? The Complete Conversion Chart

For this glp-1 weight loss page, the 2026 refresh focuses on semaglutide, tirzepatide, safety signals, how, many, units so the article stays close to the question behind "How Many Units Is 1 mg of Semaglutide or Tirzepatide? The Complete Conversion Chart".

The useful details are the practical ones: what to verify, what changes risk or cost, and which details separate How Many Units Is 1 mg of Semaglutide or Tirzepatide? The Complete Conversion Chart from nearby GLP-1, peptide, hormone, or provider-comparison searches.

Readers can use the added context to bring sharper questions to a licensed provider before making a treatment, cost, or care decision.

How Many Units Is 1 mg of Semaglutide or Tirzepatide? The Complete Conversion Chart custom 2026 image for glp-1 weight loss on FormBlends

Custom 2026 image for How Many Units Is 1 mg of Semaglutide or Tirzepatide? The Complete Conversion Chart, glp-1 weight loss, and better treatment decision-making.

Image description: Unique image for this page covering How Many Units Is 1 mg of Semaglutide or Tirzepatide? The Complete Conversion Chart, glp-1 weight loss, safety, cost, provider selection, and patient decision-making.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Written by FormBlends Editorial Research

Prepared by FormBlends Editorial Research. Claims are checked against primary regulatory, trial, label, and public-health sources where available. Reviewed by FormBlends Medical Team for medical accuracy, sourcing, and patient-safety framing.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded GLP-1 medications starting at $99/month with free shipping.

Next Best Reads

GLP-1 Weight Loss

How Many Units Is 5 mg of Semaglutide or Tirzepatide? The Definitive Conversion Guide

Complete unit conversion for 5 mg doses of semaglutide and tirzepatide at every common concentration, plus how to draw accurately with U-100 syringes.

GLP-1 Weight Loss

How Many Units Is 5 mg? The Complete Conversion Chart for Compounded Semaglutide and Tirzepatide

Complete unit conversion for 5 mg doses across all compounded semaglutide and tirzepatide concentrations, plus how to draw accurately every time.

GLP-1 Weight Loss

How Many Units Is 5mg? The Complete Conversion Chart for Compounded Semaglutide and Tirzepatide

How many units is 5mg of semaglutide or tirzepatide? Complete conversion chart for every compounded concentration with U-100 syringe instructions.

GLP-1 Weight Loss

How Many Units Is 0.5 mg of Semaglutide or Tirzepatide? The Complete Conversion Guide

How many units is 0.5mg of semaglutide or tirzepatide? Full conversion chart for every compounded concentration with U-100 insulin syringe instructions.

GLP-1 Weight Loss

25 mg to Units: The Complete Conversion Chart for Compounded Semaglutide and Tirzepatide

How many units is 25 mg of semaglutide or tirzepatide? Full conversion charts for every compounded concentration, plus the math formula you need.

GLP-1 Weight Loss

How Many Units Is 2.4 mg? Complete Conversion Chart for Semaglutide and Tirzepatide

Unit-by-unit conversion for 2.4 mg semaglutide and tirzepatide at every common concentration, plus how to draw the dose safely with a U-100 syringe.

Free Tools

Provider-informed calculators to support your weight loss journey.